160 related articles for article (PubMed ID: 9433446)
21. Bigger may be better: targeted beta2-agonist therapy.
Ind PW
Am J Respir Crit Care Med; 2005 Sep; 172(6):656-7. PubMed ID: 16148193
[No Abstract] [Full Text] [Related]
22. The use of patch formulation of tulobuterol, a long-acting beta2-adrenoreceptor agonist, in the treatment of severe pediatric asthma.
Yoshihara S; Yamada Y; Abe T; Arisaka O
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):879-80. PubMed ID: 16802779
[No Abstract] [Full Text] [Related]
23. The use of inhaled formoterol in the treatment of asthma.
Berger WE
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
[TBL] [Abstract][Full Text] [Related]
24. Whither beta-adrenoceptor agonists in the treatment of asthma.
Seale JP
Prog Clin Biol Res; 1988; 263():367-77. PubMed ID: 2454492
[No Abstract] [Full Text] [Related]
25. Adrenergic agonists and bronchodilator aerosol therapy in asthma.
Shim C
Clin Chest Med; 1984 Dec; 5(4):659-68. PubMed ID: 6151440
[TBL] [Abstract][Full Text] [Related]
26. Safety of long-acting β-agonists in asthma.
Rodrigo GJ; Castro-Rodriguez JA
Thorax; 2012 Nov; 67(11):1015. PubMed ID: 22577130
[No Abstract] [Full Text] [Related]
27. Beta-adrenergic bronchodilators.
Nelson HS
N Engl J Med; 1995 Aug; 333(8):499-506. PubMed ID: 7623883
[No Abstract] [Full Text] [Related]
28. [Refractory asthma: underlying mechanisms, diagnosis and new therapeutic approach].
Manise M; Louis R
Rev Med Liege; 2008; 63(7-8):494-9. PubMed ID: 18771228
[TBL] [Abstract][Full Text] [Related]
29. [Beta-2 agonists].
Devillier P
Rev Mal Respir; 1998 Sep; 15 Suppl 2():S45-50. PubMed ID: 9809344
[No Abstract] [Full Text] [Related]
30. [Long-acting beta2-agonist bronchodilators safety for asthma treatment].
Giubergia V
Arch Argent Pediatr; 2009 Aug; 107(4):291-3. PubMed ID: 19753432
[No Abstract] [Full Text] [Related]
31. Long-acting beta 2-agonists. Role in primary care asthma treatment.
D'Urzo AD
Can Fam Physician; 1997 Oct; 43():1773-7. PubMed ID: 9356758
[TBL] [Abstract][Full Text] [Related]
32. [beta2-Sympathomimetics: dangers in asthma therapy? Lessons from the SMART1 Study].
Riedl-Seifert R
Dtsch Med Wochenschr; 2007 Mar; 132(12):633; author reply 633-4. PubMed ID: 17357910
[No Abstract] [Full Text] [Related]
33. [Long acting beta-2 agonists. Discussion of their use in asthma].
Aumiller J
MMW Fortschr Med; 2009 Apr; 151(15):14. PubMed ID: 19728671
[No Abstract] [Full Text] [Related]
34. Safety of long-acting β2-agonists in asthma.
de Benedictis FM; Carloni I
Thorax; 2012 Nov; 67(11):1014-5. PubMed ID: 22550084
[No Abstract] [Full Text] [Related]
35. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
Kim D; Glaum M; Lockey R
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
[TBL] [Abstract][Full Text] [Related]
36. [Use of delayed-action beta-2 mimetics in the management of chronic obstructive bronchial diseases--for].
Muir JF; Cuvelier A
Rev Mal Respir; 1999 Jan; 16 Suppl 3():S75-6. PubMed ID: 10088257
[No Abstract] [Full Text] [Related]
37. [Long-acting beta-2-agonists in the treatment of asthma].
Rochat T
Schweiz Med Wochenschr; 1994 Oct; 124(39):1714-9. PubMed ID: 7939538
[TBL] [Abstract][Full Text] [Related]
38. Long-acting beta 2-agonists: the new symptom controllers for asthma.
Jenkins CR
Med J Aust; 1999 Sep; 171(5):255-8. PubMed ID: 10495758
[No Abstract] [Full Text] [Related]
39. [Use of delayed-action beta-2 mimetics in the management of chronic obstructive bronchial disease--against].
Terrioux P
Rev Mal Respir; 1999 Jan; 16 Suppl 3():S76-7. PubMed ID: 10088258
[No Abstract] [Full Text] [Related]
40. [Receptor pharmacology (2): Developing trends in receptor pharmacology. Adrenergic bronchodilators].
Svedmyr N
Lakartidningen; 1978 Nov; 75(44):4019-22. PubMed ID: 29998
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
